Psoriasis: Scratching The Surface
A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
In a study published in the Journal of Clinical Investigation, researchers led by Manfred Kopf at the Swiss Federal Institute of Technology in Zürich, Switzerland found that mice lacking interleukin-36 (IL-36) were protected from immune-mediated skin inflammation. These results indicate that IL-36 might be a useful therapeutic target in the treatment of psoriasis.
TITLE: Psoriasiform dermatitis is driven by interleukin-36-mediated dendritic cell-keratinocyte crosstalk
View this article at: http://www.jci.org/articles/view/63451?key=94c50375c771888cd255
Adapted by MNT from original media release